Alpha DNA Investment Management’s Royce Value Trust RVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-24,400
Closed -$337K – 214
2023
Q2
$337K Hold
24,400
– – 0.11% 139
2023
Q1
$331K Hold
24,400
– – 0.1% 138
2022
Q4
$324K Buy
+24,400
New +$336K 0.11% 143

Other funds holding RVT

Alpha DNA Investment Management's RVT Position: Q3 2023 in Review

Alpha DNA Investment Management sold out of Royce Value Trust (RVT) in Q3 2023, closing a stake of 24,400 shares — an estimated $337K sold.

Alpha DNA Investment Management first reported a position in RVT in Q4 2022 and held it in 3 quarters. The position peaked at $337K in Q2 2023. 161 funds tracked by Wall St. Rank hold RVT as of Q3 2023.

  • Alpha DNA Investment Management reported no remaining Royce Value Trust position as of Q3 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 24,400 Royce Value Trust shares in Q3 2023, an estimated $337K.
  • Alpha DNA Investment Management first reported a position in Royce Value Trust in Q4 2022 and held it in 3 quarters.
  • Alpha DNA Investment Management's Royce Value Trust position peaked at $337K in Q2 2023.
  • 161 funds tracked by Wall St. Rank held Royce Value Trust as of Q3 2023.

Based on Alpha DNA Investment Management's 13F filing for Q3 2023, filed 7 Nov 2023.